CLONAL EVOLUTION OF AN IMMUNOBLASTIC TYPE NON-HODGKINS-LYMPHOMA WITH DER(6)T(1-6)(Q11-P11) AS ITS PRIMARY CYTOGENETIC ABNORMALITY

被引:8
作者
GAGOS, S [1 ]
IATRIDOUKYRKOU, K [1 ]
LIOSI, A [1 ]
KARAKITSOS, P [1 ]
PAPAGEORGAKI, P [1 ]
KYROUDI, A [1 ]
PATHAK, S [1 ]
机构
[1] UNIV ATHENS,ATHENS SCH MED,DEPT PATHOL,DIAGNOST CYTOL & CYTOGENET LAB,ATHENS,GREECE
关键词
D O I
10.1016/0165-4608(94)00112-O
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Recurrent pleural effusions from a 45-year-old man who was diagnosed as having non-Hodgkin's lymphoma of immunoblastic type were studied cytogenetically. The majority of the metaphases were tetraploid, but there were also lymphoma cells observed with pseudodiploid chromosome constitutions. Cytogenetic analysis by G-banding revealed the existence of at least two cell populations. The karyotype of the minor pseudodiploid clone, which exhibited partial trisomy of 1q11qter and monosomy of 6p11pter as sole abnormalities, was 46,XY,der(6)t(1;6)(q11;p11). The karyotype of the major clone was 92,XXYY, -1,der(6)t(1;6)(q11;p11)xa,+9. The ancestral diploid clone, carrier of the balanced translocation involving chromosomes 1 and 6, was not observed even in the first pleural effusion harvest. The high proportion of tetraploid cells in the recurrent effusions was an indication that these cells were favorably selected in the environment of the somatic cavity. Our cytogenetic findings suggest that partial trisomy of 1q may be a crucial secondary chromosomal abnormality in highly malignant non-Hodgkin's lymphoma. This genetic imbalance was predetermined from the primary abnormality and may be responsible for further tumor progression, as suggested from the clonal evolution in this particular case and, therefore, may be associated with the aggressive biologic behavior of malignant cells.
引用
收藏
页码:59 / 63
页数:5
相关论文
共 28 条
[1]  
ATKIN NB, 1979, CANCER, V44, P604, DOI 10.1002/1097-0142(197908)44:2<604::AID-CNCR2820440230>3.0.CO
[2]  
2-G
[3]  
BLOOMFIELD CD, 1983, CANCER RES, V43, P2975
[4]   PARTIAL TRISOMY 1Q IN IDIOPATHIC MYELOFIBROSIS [J].
DONTI, E ;
TABILIO, A ;
BOCCHINI, F ;
FALZETTI, F ;
MARTELLI, MF ;
GRIGNANI, F ;
DONTI, GV .
LEUKEMIA RESEARCH, 1990, 14 (11-12) :1035-&
[5]   KARYOTYPIC EVOLUTION IN A B-CELL LYMPHOMA [J].
FITZGERALD, PH ;
MORRIS, CM ;
ROSMAN, I ;
ARCHER, SA ;
HOLLINGS, PE .
CANCER GENETICS AND CYTOGENETICS, 1987, 24 (02) :271-279
[6]   PARTIAL TRISOMY-1Q - A NONRANDOM PRIMARY CHROMOSOMAL ABNORMALITY IN MYELODYSPLASTIC SYNDROMES [J].
FONATSCH, C ;
HAASE, D ;
FREUND, M ;
BARTELS, H ;
TESCH, H .
CANCER GENETICS AND CYTOGENETICS, 1991, 56 (02) :243-253
[7]  
HEIM S, 1987, HUM GENET, V75, P70
[8]  
HEIM S, 1987, CANCER CYTOGENETICS
[9]   POSSIBILITY OF LATENT CENTROMERES AND A PROPOSED NOMENCLATURE SYSTEM FOR TOTAL CHROMOSOME AND WHOLE ARM TRANSLOCATIONS [J].
HSU, TC ;
PATHAK, S ;
CHEN, TR .
CYTOGENETICS AND CELL GENETICS, 1975, 15 (01) :41-49
[10]   CYTOGENETIC DELETION MAPS OF HEMATOLOGIC NEOPLASMS - CIRCUMSTANTIAL EVIDENCE FOR TUMOR-SUPPRESSOR LOCI [J].
JOHANSSON, B ;
MERTENS, F ;
MITELMAN, F .
GENES CHROMOSOMES & CANCER, 1993, 8 (04) :205-218